메뉴 건너뛰기




Volumn 22, Issue 4, 2012, Pages 1686-1689

Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists

Author keywords

Asthma; CRTH2; DP; Dual Antagonist; GPCR; PGD2; SAR

Indexed keywords

AMG 009; AMIDE; BISARYL ETHER; CHEMOATTRACTANT RECEPTOR HOMOLOGOUS MOLECULE EXPRESSED ON TH2 CELL; CHEMOATTRACTANT RECEPTOR HOMOLOGOUS MOLECULE EXPRESSED ON TH2 CELL ANTAGONIST; ETHER DERIVATIVE; G PROTEIN COUPLED RECEPTOR; PHENYLACETIC ACID; PHENYLACETIC ACID DERIVATIVE; PROSTANOID D RECEPTOR; PROSTANOID D RECEPTOR ANTAGONIST; SULFONAMIDE; UNCLASSIFIED DRUG;

EID: 84862831554     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.12.107     Document Type: Article
Times cited : (5)

References (24)
  • 12
    • 85030489299 scopus 로고    scopus 로고
    • Presented at 19th Annual Congress of the European Respiratory Society (ERS), September
    • Oxagen Ltd Novel CRTH2 Antagonist Shows Potential in Moderate Persistent Asthma: Presented at 19th Annual Congress of the European Respiratory Society (ERS), September 18, 2009. http://www.docguide.com/news/content.nsf/news/ 852576140048867A85257635005BC1C3.
    • (2009) Oxagen Ltd Novel CRTH2 Antagonist Shows Potential in Moderate Persistent Asthma , vol.18


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.